A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

NCT03520998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Mild to Moderate Alzheimer Disease

Interventions

DRUG: GRF6019

Sponsor

Alkahest, Inc.